Both in Biotechnology
Senti Biosciences Holdings vs Intensity Therapeutics
Over the past year SNTI returned −78.0% and INTS returned −44.3%; their daily moves had a correlation of 0.06.
SNTI −78.0% INTS −44.3%Growth of $1, one year, split-adjusted
| Metric | SNTI | INTS |
|---|---|---|
| Price | $0.3075 | $3.42 |
| Market cap | $9.6M | $11.2M |
| Today | −0.81% | −6.30% |
| 1 month | −18.4% | −19.5% |
| 6 months | −60.2% | −39.8% |
| Year to date | −70.4% | −66.7% |
| 1 year | −77.9% | −43.6% |
| Revenue growth (YoY) | — | — |
| Gross margin | 100.0% | — |
| Net margin | −75000.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 174.1× | — |
| Net cash | $2.5M | $9.5M |
| Dividend yield | — | — |
| Volatility (60d) | 134.3% | 56.9% |
| Short % of float | 4.9% | 1.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).